Guanhao Biotech Co.,Ltd. (SHE:300238)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Agent Products	86.69M
Agent Products Growth	-2.17%
Biological Hard Brain (Spine) Membrane Patch	74.77M
Biological Hard Brain (Spine) Membrane Patch Growth	-14.70%
Type B Hard Brain (Spine) Membrane Patch	72.14M
Type B Hard Brain (Spine) Membrane Patch Growth	21.52%
Cell Technology Service	39.48M
Cell Technology Service Growth	-21.45%
Thoracic Surgery Repair Membrane	38.99M
Thoracic Surgery Repair Membrane Growth	-3.71%
Benvimod	37.01M
Benvimod Growth	-25.15%
Sterile Biological Wound Protection Membrane	13.35M
Sterile Biological Wound Protection Membrane Growth	21.03%
Rental and Other Services	13.34M
Rental and Other Services Growth	-9.16%
Breast Patch	1.09M
Breast Patch Growth	-43.66%
Other	623.04K
Other Growth	-9.46%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
China	377.48M
China Growth	-6.60%